Skip to main content
Fig. 3 | BMC Microbiology

Fig. 3

From: Intra-wound vancomycin powder for the eradication of periprosthetic joint infection after debridement and implant exchange: experimental study in a rat model

Fig. 3

X-ray evaluation of the knee joint and prosthesis on days 28. Control (no antibiotics); SV: Systemic vancomycin (intraperitoneal injection, 88 mg/kg, every 12 h); VP: Intra-wound vancomycin powder (before closure of the capsule, 88 mg/kg, single dosage); SV&VP: Systemic vancomycin & intra-wound VP (intraperitoneal injection, 88 mg/kg, every 12 h; combined with intra-wound VP before closure of the capsule, 88 mg/kg, single dosage). The red arrow indicates the position of prosthesis and destruction of the bone

Back to article page

BMC Microbiology

ISSN: 1471-2180

Contact us